TE_130
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | MLT1L |
---|---|
TE superfamily | MaLR |
TE class | LTR |
Gene | - |
Class | Intergenic |
Coding | Non-coding |
Tumor-specific score | 0.31 |
Counts of samples | TCGA_tumor:150; TCGA_normal:23; GTEx:533 |
TSS | chr1(-):14822938 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_130.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):14819028,14819048,14822632,14822939 |
teRNA_130.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):14821027,14821047,14822632,14822939 |
teRNA_130.3 | - | Intergenic | Non-coding | Non-coding | chr1(-):14805428,14805448,14822632,14822939 |
teRNA_130.4 | - | Intergenic | Non-coding | Non-coding | chr1(-):14818342,14818362,14822632,14822939 |
teRNA_130.5 | - | Intergenic | Non-coding | Non-coding | chr1(-):14819032,14819052,14822632,14822939 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.